Klotho Neurosciences’ treatment of amyotrophic lateral sclerosis was granted FDA orphan designation, according to a post to the agency’s website.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KLTO:
- 3 Penny Stocks to Watch Now, 7/1/25
- Klotho Neurosciences Begins Manufacturing Gene Therapy for ALS
- Klotho Neurosciences moves forward with KLTO-202 manufacturing and development
- Klotho Neurosciences, ORCLS announce plan to study Blue Zone
- Klotho Neurosciences, SkyBell mutually terminate Share Exchange Agreement